The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Transcriptional Cross Talk between NF-κB and p53
Open accessAbstract
Many cellular stimuli result in the induction of both the tumor suppressor p53 and NF-kappaB. In contrast to activation of p53, which is associated with the induction of apoptosis, stimulation of NF-kappaB has been shown to promote resistance to programmed cell death. These observations suggest that a regulatory mechanism must exist to integrate these opposing outcomes and coordinate this critical cellular decision-making event. Here we show that both p53 and NF-kappaB inhibit each other's ability to stimulate gene expression and that this process is controlled by the relative levels of each transcription factor. Expression of either wild-type p53 or the RelA(p65) NF-kappaB subunit suppresses stimulation of transcription by the other factor from a reporter plasmid in vivo. Moreover, endogenous, tumor necrosis factor alpha-activated NF-kappaB will inhibit endogenous wild-type p53 transactivation. Following exposure to UV light, however, the converse is observed, with p53 downregulating NF-kappaB-mediated transcriptional activation. Both p53 and RelA(p65) interact with the transcriptional coactivator proteins p300 and CREB-binding protein (CBP), and we demonstrate that these results are consistent with competition for a limiting pool of p300/CBP complexes in vivo. These observations have many implications for regulation of the transcriptional decision-making mechanisms that govern cellular processes such as apoptosis. Furthermore, they suggest a previously unrealized mechanism through which dysregulated NF-kappaB can contribute to tumorigenesis and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since p53 inhibits RELA by competing for CBP binding (Webster and Perkins, 1999), p53 likely limits the IL1 arm of the SASP by reducing NF-κB activity.”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Webster and Perkins, 1999
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,586
Suppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Flagged first, then by citations
Research works printed but not linked: 11
- Bannister A. J., 1995, Oncogene, 11, 2509
- Eck S. L., 1993, Mol. Cell. Biol., 13, 6530
- el-Deiry W. S., 1994, Cancer Res., 54, 1169
- 10.1073/pnas.94.4.1074 · DOI
- Israel A., 1997, Nature, 388, 519
- Jiang H., 1994, Oncogene, 9, 3397
- Mukhopadhyay T., 1996, Int. J. Oncol., 9, 715
- Perkins N. D., 1994, Mol. Cell. Biol., 14, 6570
- Ravi R., 1998, Cancer Res., 58, 4531
- Stein B., 1993, Mol. Cell. Biol., 13, 3964
- Vojtesek B., 1995, Oncogene, 10, 389
Cited by
Sorted by citations
Items 301–400 of 600
Rasmussen, M. K., Iversen, L., Johansen, C., Finnemann, J., Olsen, L. S., Kragballe, K., & Gesser, B. (2008) · Inflammation Research · doi:10.1007/s00011-007-7220-1 · Cited by 37
Stachowska, E., Baśkiewicz‐Masiuk, M., Dziedziejko, V., Adler, G., Bober, J., Machaliński, B., & Chlubek, D. (2007) · Lipids · doi:10.1007/s11745-007-3072-2 · Cited by 37
Marwaha, V., Chen, Y., Helms, E., Arad, S., Inoue, H., Bord, E., Kishore, R., Sarkissian, R. D., Gilchrest, B. A., & Goukassian, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503245200 · Cited by 37
Vlachostergios, P. J., Patrikidou, A., Daliani, D., & Papandreou, C. N. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00824.x · Cited by 36
Cylindrospermopsin induced transcriptional responses in human hepatoma HepG2 cells
Štraser, A., Filipič, M., & Žegura, B. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.05.012 · Cited by 35
Chen, Y.-C., Young, M.-J., Chang, H.-P., Liu, C.-Y., Lee, C.-C., Tseng, Y., Wang, Y., Chang, W., & Hung, J. (2022) · Oncogenesis · doi:10.1038/s41389-022-00397-4 · Cited by 35
Yoon, J. W., Lamm, M. L. G., Iannaccone, S., Higashiyama, N., Leong, K.-F., Iannaccone, P. M., & Walterhouse, D. O. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.06.006 · Cited by 35
Melnick, M., Chen, H., Zhou, Y., & Jaskoll, T. F. (2001) · The Anatomical Record · doi:10.1002/1097-0185(20010301)262:3 · Cited by 35
Reciprocal regulation of p53 and NF-κB by diacylglycerol kinase ζ
Tanaka, T., Tsuchiya, R., Hozumi, Y., Nakano, T., Okada, M., & Goto, K. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.009 · Cited by 34
Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xLratio
Goloudina, A. R., Mazur, S. J., Appella, E., Garrido, C., & Demidov, O. N. (2012) · Cell Cycle · doi:10.4161/cc.19901 · Cited by 37
Ghasemi, K., & Ghasemi, K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174593 · Cited by 34
Milani, D., Caruso, L., Zauli, E., Owaifeer, A. M. A., Secchiero, P., Zauli, G., Gemmati, D., & Tisato, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871583 · Cited by 37
NF-kappaB function in the human myometrium during pregnancy and parturition.
Cookson, V. J., & Chapman, N. (2010) · PubMed · doi:10.14670/hh-25.945 · Cited by 35
Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-κB subunit p65
Taneja, P., Mallakin, A., Matise, L. A., Frazier, D. P., Choudhary, M., & Inoue, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210568 · Cited by 34
Schneider‐Merck, T., Pohnke, Y., Kempf, R., Christian, M., Brosens, J. J., & Gellersen, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503459200 · Cited by 34
Global Analysis of CPEBs Reveals Sequential and Non-Redundant Functions in Mitotic Cell Cycle
Giangarrà, V., Igea, A., Castellazzi, C. L., Bava, F.-A., & Méndez, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138794 · Cited by 35
Neuronal κB-binding Factors Consist of Sp1-related Proteins
Mao, X. R., Moerman, A., & Barger, S. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204292200 · Cited by 35
Tsuchiya, R., Tanaka, T., Hozumi, Y., Nakano, T., Okada, M., Topham, M. K., Iino, M., & Goto, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.11.011 · Cited by 33
Szołtysek, K., Janus, P., Zając, G., Stokowy, T., Walaszczyk, A., Widłak, W., Wojtaś, B., Gielniewski, B., Cockell, S., Perkins, N. D., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-5211-y · Cited by 35
Self-citationHiggins, C. E., Tang, J., Mian, B. M., Higgins, S. P., Gifford, C. C., Conti, D. J., Meldrum, K. K., Samarakoon, R., & Higgins, P. J. (2019) · The FASEB Journal · doi:10.1096/fj.201900943r · Cited by 34
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
Kong, L. R., Ong, R., Tan, T. Z., Salleh, N. A. B. M., Thangavelu, M. T., Chan, J. V., Koh, L. Y. J., Periyasamy, G., Lau, J. A., Le, T. B. U., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15608-y · Cited by 34
The functional genomic response of developing embryonic submandibular glands to NF-kappaB inhibition
Melnick, M., Chen, H., Zhou, Y. M., & Jaskoll, T. F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-15 · Cited by 33
Ho, J.-Y., Lu, H., Cheng, H.-H., Kuo, Y.-C., Lee, Y.-L. A., & Cheng, C. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00639-4 · Cited by 32
Review: NF-kB activation in canine cancer
Schlein, L. J., & Thamm, D. H. (2022) · Veterinary Pathology · doi:10.1177/03009858221092017 · Cited by 32
Synthesis and Mechanistic Studies of a Novel Homoisoflavanone Inhibitor of Endothelial Cell Growth
Basavarajappa, H. D., Lee, B., Fei, X., Lim, D., Callaghan, B., Mund, J. A., Case, J., Gangaraju, R., Seo, S., & Corson, T. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095694 · Cited by 32
Zhou, Y., Du, W., Koretsky, T., Bagby, G. C., & Pang, Q. (2008) · Blood · doi:10.1182/blood-2007-12-130211 · Cited by 32
Crosstalk between the NF‐κB activating IKK‐complex and the CSN signalosome
Orel, L., Neumeier, H., Hochrainer, K., Binder, B. R., & Schmid, J. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00866.x · Cited by 32
Zhang, X., Liu, S. S., Ma, J., & Qu, W. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154633 · Cited by 32
The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma
Jayab, N. N. A., Abed, A., Talaat, I. M., & Hamoudi, R. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.030 · Cited by 31
Das, B., Young, D., Vasanji, A., Gupta, S., Sarkar, S., & Sen, S. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq068 · Cited by 31
RetractedSun, Q., Hu, B., Fu, P., Tang, W., Zhang, X., Zhan, H., Sun, C., He, Y., Song, K., Xiao, Y., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy113 · Cited by 31
Huang, T.-I., & Hsieh, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6624976 · Cited by 31
Maiuri, M. C., TAJANA, G., Iuvone, T., Stefano, D. D., Mele, G., Ribecco, M. T. S., Cinelli, M. P., Romano, M. F., Turco, M. C., & Carnuccio, R. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63280-4 · Cited by 31
Mori, N., Morishita, M., Tsukazaki, T., & Yamamoto, N. (2003) · International Journal of Cancer · doi:10.1002/ijc.11146 · Cited by 31
Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer
Börnigen, D., Tyekucheva, S., Wang, X., Rider, J. R., Lee, G. M., Mucci, L. A., Sweeney, C. J., & Huttenhower, C. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004820 · Cited by 30
Leech, M. T., Xue, J. R., Dacumos, A., Hall, P., Santos, L. L., Yang, Y. H., Li, M., Kitching, A. R., & Morand, E. F. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03629.x · Cited by 30
Wątroba, M., Maślińska, D., & Maśliński, S. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0039-1 · Cited by 30
Nuclear factor-κB as a predictor of treatment response in breast cancer
Garg, A. K., Hortobágyi, G. N., Aggarwal, B. B., Şahin, A. A., & Buchholz, T. A. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00001 · Cited by 30
Relja, B., Töttel, E., Breig, L., Henrich, D. M., Schneider, H., Marzi, İ., & Lehnert, M. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0216-1 · Cited by 30
Goodson, M. S., Crookes‐Goodson, W. J., Kimbell, J. R., & McFall‐Ngai, M. (2006) · Biological Bulletin · doi:10.2307/4134573 · Cited by 31
Bashash, D., Safaroghli‐Azar, A., Bayati, S., Razani, E., Pourbagheri‐Sigaroodi, A., Gharehbaghian, A., Momeny, M., Sanjadi, M., Rezaei–Tavirani, M., & Ghaffari, S. H. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.08.010 · Cited by 30
Deep, G., Gangar, S. C., Oberlies, N. H., Kroll, D. J., & Agarwal, R. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20670 · Cited by 30
Deregowski, V., Delhalle, S., Benoît, V., Bours, V., & Merville, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01151-6 · Cited by 30
Park, J.-H., Rasch, M. G., Qiu, J., Lund, I. K., & Egeblad, M. (2015) · Neoplasia · doi:10.1016/j.neo.2015.04.003 · Cited by 29
Effects of Mycoplasmas on the Host Cell Signaling Pathways
Borchsenius, S. N., Vishnyakov, I. E., Chernova, O. A., Chernov, V. M., & Barlev, N. A. (2020) · Pathogens · doi:10.3390/pathogens9040308 · Cited by 29
Lavon, I., Pikarsky, E., Gutkovich, E., Goldberg, I., Bar, J., Oren, M., & Ben‐Neriah, Y. (2003) · PubMed · Cited by 29
Pekar, O., Molotski, N., Savion, S., Fein, A., Toder, V., & Torchinsky, A. M. (2007) · Reproduction · doi:10.1530/rep-07-0086 · Cited by 29
Arnicolide D exerts anti-melanoma effects and inhibits the NF-κB pathway
Zhu, P., Zheng, Z., Fu, X., Li, J., Yin, C., Chou, J., Wang, Y., Liu, Y., Chen, Y., Bai, J., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153065 · Cited by 28
Ghose, J., & Bhattacharyya, N. P. (2015) · RNA Biology · doi:10.1080/15476286.2015.1014288 · Cited by 28
Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression
Ortega, F. J., Moreno‐Navarrete, J. M., Mayas, D., Sérino, M., Rodríguez‐Hermosa, J. I., Ricart, W., Luche, É., Burcelin, R., Tinahones, F. J., Frühbeck, G., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.163 · Cited by 31
Genov, M. N., Kreiseder, B., Nagl, M., Drucker, E., Wiederstein, M., Muellauer, B., Krebs, J., Grohmann, T., Pretsch, D., Baumann, K., et al. (2016) · Journal of Cancer · doi:10.7150/jca.13614 · Cited by 28
Dual role of TMS1/ASC in death receptor signaling
Parsons, M. J., & Vertino, P. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209684 · Cited by 28
Youn, B. W., Fiala, E. S., & Sohn, O. S. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc401_7 · Cited by 28
Kawai, H., Yamada, Y., Tatsuka, M., Niwa, O., Yamamoto, K., & Suzuki, F. (1999) · PubMed · Cited by 28
Cooperative interactions between p53 and NFκB enhance cell plasticity
Bisio, A., Zámborszky, J., Zaccara, S., Lion, M., Tebaldi, T., Sharma, V., Raimondi, I., Alessandrini, F., Ciribilli, Y., & Inga, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2545 · Cited by 27
Effects of mycoplasma infection on the host organism response via p53/NF‐κB signaling
Borchsenius, S. N., Daks, A. A., Fedorova, O., Chernova, O. A., & Barlev, N. A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26781 · Cited by 27
Li, Y., Xu, Y., Ling, M., Yang, Y., Wang, S., Li, Z., Zhou, J., Wang, X., & Liu, Q. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901677 · Cited by 27
Endogenous Inhibitors of Nuclear Factor-κB, An Opportunity for Cancer Control
Chen, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2096 · Cited by 27
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation
Wu, H. H., Leng, S., Eisenstat, D. D., Sergi, C. M., & Leng, R. P. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217614 · Cited by 27
Cross‐validation of Murine UV Signal Transduction Pathways in Human Skin†
Einspahr, J. G., Bowden, G. T., Alberts, D. S., McKenzie, N. E., Saboda, K., Warneke, J. A., Salasche, S. J., Ranger‐Moore, J., Curiel‐Lewandrowski, C. N., Nagle, R. B., et al. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00287.x · Cited by 26
Regulation of RelA (p65) Function by the Large Subunit of Replication Factor C
Anderson, L. A., & Perkins, N. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.721-732.2003 · Cited by 26
Self-citationBorthwick, E. B., Korobko, I. V., Luke, C. T., Drel, V. R., Fedyshyn, Y., Ninkina, N. N., Дробот, Л. Б., & Buchman, V. L. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.075 · Cited by 26
NS5ATP9 gene regulated by NF-κB signal pathway
Li, K., Ma, Q., Shi, L., Dang, C., Yuan, H., Wang, Q., Li, Y., Fan, W., Zhang, L., & Cheng, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.08.005 · Cited by 25
Kapur, N., Mir, H., Sonpavde, G., Jain, S. R., Bae, S., Lillard, J. W., & Singh, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.001 · Cited by 26
Li, H., Wang, S., Chen, Y., Lǚ, K., Yin, B., Li, S., He, J., & Li, C. (2017) · Scientific Reports · doi:10.1038/srep45821 · Cited by 25
Cruz-Garcia, L., O’Brien, G., Donovan, E. M., Gothard, L., Boyle, S., Laval, A., Testard, I., Ponge, L., Woźniak, G., Miszczyk, L., et al. (2018) · Health Physics · doi:10.1097/hp.0000000000000844 · Cited by 25
The NF-κB Nucleolar Stress Response Pathway
Thoms, H. C., & Stark, L. A. (2021) · Biomedicines · doi:10.3390/biomedicines9091082 · Cited by 24
Malla, B. A., Ali, A., Maqbool, I., Dar, N. A., Ahmad, S. B., Alsaffar, R. M., & Rehman, M. U. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2137241 · Cited by 24
Spatio-temporal protein dynamics in single living cells
Ankers, J., Spiller, D. G., White, M., & Harper, C. V. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.07.001 · Cited by 25
Chapman, N., Webster, G., Gillespie, P. J., Wilson, B. J., Crouch, D. H., & Perkins, N. D. (2002) · Biochemical Journal · doi:10.1042/bj20020444 · Cited by 24
Self-citationGarbati, M. R., Alço, G., & Gilmore, T. D. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.10.018 · Cited by 24
Saha, S., Bhattacharjee, P., Guha, D., Kajal, K., Khan, P., Chakraborty, S., Mukherjee, S., Paul, S., Manchanda, R. K., Khurana, A. K., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3061 · Cited by 23
Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Breda, S. G. J. V., Jennen, D. G. J., & Kleinjans, J. C. S. (2015) · Mutagenesis · doi:10.1093/mutage/gev036 · Cited by 23
Jambalganiin, U., Tsolmongyn, B., Koide, N., Odkhuu, E., Naiki, Y., Komatsu, T., Yoshida, T., & Yokochi, T. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.032 · Cited by 23
Yang, P., Huang, W., Lin, Y., Huang, W., Wu, H., Chen, W., Chang, Y., Chou, C., Tzeng, C., Chen, Y., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00712.x · Cited by 24
Molecular changes induced by the curcumin analogue D6 in human melanoma cells
Rozzo, C., Fanciulli, M., Fraumene, C., Corrias, A., Cubeddu, T., Sassu, I., Cossu, S., Nieddu, V., Galleri, G., Azara, E., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-37 · Cited by 23
Huang, J., Chen, K., Huang, J., Gong, W., Dunlop, N. M., Howard, O. M. Z., Bian, X., Gao, Y., & Wang, J. M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn266 · Cited by 23
Sansfaçon, J. G., Coulombe, G., Langlois, M., Langlois, A., Paquet, M., Carrier, J. C., Feng, G., Qu, C., & Rivard, N. (2016) · Oncotarget · doi:10.18632/oncotarget.11601 · Cited by 25
Wagner, V. P., Martins, M. A. T., Martins, M. D., Warner, K. A., Webber, L. P., SQUARIZE, C. H., Nor, J. E., & CASTILHO, R. M. (2016) · Oncotarget · doi:10.18632/oncotarget.12195 · Cited by 23
Dorandish, S., Williams, A., Atali, S., Sendo, S., Price, D., Thompson, C., Guthrie, J. W., Heyl, D., & Evans, H. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-88574-0 · Cited by 23
High constitutive level of NF-κB is crucial for viability of adenocarcinoma cells
Smirnov, A., Ruzov, A. S., Budanov, A. V., Prokhortchouk, A., Ivanov, A. V., & Prokhortchouk, E. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400853 · Cited by 23
Regulation of NF-κB by atypical activators and tumour suppressors
Perkins, N. D. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320936 · Cited by 23
Self-citationAmeyar‐Zazoua, M., Larochette, N., Dorothée, G., Daugas, É., Haddada, H., Gouloumet, V., Métivier, D., Stancou, R., Mami‐Chouaib, F., Kroemer, G., et al. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700434 · Cited by 25
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
Chi, A., van der Watt, P. J., Wei, W., Birrer, M. J., & Leaner, V. D. (2021) · BMC Cancer · doi:10.1186/s12885-021-07819-3 · Cited by 22
Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells
Terrinoni, A., Dell'Arciprete, R., Fornaro, M., Stella, M., & Alberti, S. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1137 · Cited by 22
Hastie, E. L., Cataldi, M. P., Steuerwald, N., & Grdzelishvili, V. Z. (2015) · Virology · doi:10.1016/j.virol.2015.04.017 · Cited by 23
Costa, P., Wynne, D., Fifis, T., Nguyen, L. T., Perini, M. V., & Christophi, C. (2018) · BMC Cancer · doi:10.1186/s12885-018-4260-6 · Cited by 23
Chapman, N., Smyrnias, I., Anumba, D. O. C., Europe‐Finner, G. N., & Robson, S. C. (2005) · Endocrinology · doi:10.1210/en.2005-0533 · Cited by 22
The Phosphotyrosyl Phosphatase Activator Gene Is a Novel p53 Target Gene
Janssens, V., HOOF, C. V., BAERE, I. D., Merlevede, W. J., & Goris, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909370199 · Cited by 22
Agarwal, N. R., Maurya, N., Pawar, J. S., & Ghosh, I. (2016) · Cell Biology International · doi:10.1002/cbin.10619 · Cited by 21
The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling?
Cui, X., Pan, G., Chen, Y., Guo, X., Liu, T., Zhang, J., Yang, X., Cheng, M., Gao, H., & Jiang, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105683 · Cited by 21
Lodhi, N., Singh, R., Rajput, S., & Saquib, Q. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168660 · Cited by 21
Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations.
Jean, M. D. S., DEBBASCH, C., Rahmani, M., Brignole‐Baudouin, F., Feldmann, G., Warnet, J., & Baudouin, C. (2000) · PubMed · Cited by 21
Thun, G. A., Imboden, M., Berger, W., Rochat, T., & Probst-Hensch, N. M. (2013) · Journal of Asthma · doi:10.3109/02770903.2012.757776 · Cited by 21
Chang, P.-Y., & Miyamoto, S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0259 · Cited by 21
Mayevska, O. M., Shuvayeva, G., Igumentseva, N. I., Havrylov, S., Basaraba, O., Bobak, Y. P., Barska, M., Volodko, N., Barańska, J., Buchman, V., et al. (2006) · PubMed · Cited by 21
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
Wang, Y., Hu, S., Zhang, W., Zhang, B.-F., & Yang, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01730-5 · Cited by 20
Müller, I., Beissert, S., & Kulms, D. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.481 · Cited by 20
Kaewseekhao, B., Naranbhai, V., Roytrakul, S., Namwat, W., Paemanee, A., Lulitanond, V., Chaiprasert, A., & Faksri, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134168 · Cited by 20
Shirai, Y., Shiba, H., Iwase, R., Haruki, K., Fujiwara, Y., Furukawa, K., Uwagawa, T., Ohashi, T., & Yanaga, K. K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.034 · Cited by 20
Metadata
- Authors
- Webster, G. A., & Perkins, N. D.
- Affiliations
- University of Dundee (GB)
- ORCID
- Perkins, Neil D.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1999-05-01
- Volume
- 19
- Issue
- 5
- Pages
- 3485-3495
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC84141
- OpenAlex
- W2134542375
- Cited by
- 598
- References
- 87
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 12 · 2023: 13 · 2022: 19 · 2021: 30 · 2020: 17 · 2019: 16 · 2018: 16 · 2017: 12 · 2016: 20 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Royal Society
- Tenovus
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, p53, transcriptional crosstalk, RelA/p65, P300, CREB-binding protein, transcriptional coactivator, apoptosis, TNF-α, transcriptional repression, carcinogenesis
- MeSH terms
- Binding, Competitive, Cell Line, Gene Expression Regulation, Humans, Mutation, Repressor Proteins, Transcription, Genetic, Tumor Necrosis Factor-alpha, Ultraviolet Rays, Trans-Activators, Tumor Suppressor Protein p53, NF-kappa B, Apoptosis, Genes, Reporter, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review